There was no statistically significant association between CD133 expression and age, gender, primary tumor location, presence of distant metastasis, histologic grade, tumor size, presence of lymph node metastasis and UICC staging. The gene discussed is PROM1; the disease is metastatic malignant neoplasm in the lymph nodes.